GlassScriptPhysician profile
Sarah Sherman
NPI 1073210647
$2,192.96
in general payments reported to CMS, 2019-2025
11 companies · $98.68 in 2025
The $98.68 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $232 · 2024: $1,863 · 2025: $98.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,290 · Travel and Lodging: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.56 |
| Travel and Lodging | $903.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $849.81 | 2024 | |
| Telix Pharmaceuticals | $593.75 | 2024 | |
| Sumitomo Pharma America, INC. | $315.72 | 2023-2024 | Orgovyx, Gemtesa |
| Ferring Pharmaceuticals INC. | $133.10 | 2024 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $93.60 | 2024 | Myrisk |
| Medtronic, INC. | $75.91 | 2024-2025 | Symplicity G3 |
| Dendreon Pharmaceuticals LLC | $41.93 | 2023 | Provenge |
| Terumo Medical Corporation | $26.45 | 2025 | Angio-Seal |
| Tolmar, INC. | $25.81 | 2024 | |
| Astellas Pharma Global Development | $18.85 | 2025 | Padcev |
| Abbvie INC. | $18.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.